111 related articles for article (PubMed ID: 36744340)
1. Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.
Yoshida M; Uemura T; Mizoi M; Waragai M; Sakamoto A; Terui Y; Kashiwagi K; Igarashi K
J Alzheimers Dis; 2023; 92(1):361-369. PubMed ID: 36744340
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.
Yoshida M; Higashi K; Kuni K; Mizoi M; Saiki R; Nakamura M; Waragai M; Uemura K; Toida T; Kashiwagi K; Igarashi K
Clin Chim Acta; 2015 Feb; 441():115-21. PubMed ID: 25542982
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of dementia by acrolein, amyloid-β and creatinine.
Igarashi K; Yoshida M; Waragai M; Kashiwagi K
Clin Chim Acta; 2015 Oct; 450():56-63. PubMed ID: 26196945
[TBL] [Abstract][Full Text] [Related]
4. Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein.
Mizoi M; Yoshida M; Saiki R; Waragai M; Uemura K; Akatsu H; Kashiwagi K; Igarashi K
Clin Chim Acta; 2014 Mar; 430():150-5. PubMed ID: 24508996
[TBL] [Abstract][Full Text] [Related]
5. Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease.
Waragai M; Yoshida M; Mizoi M; Saiki R; Kashiwagi K; Takagi K; Arai H; Tashiro J; Hashimoto M; Iwai N; Uemura K; Igarashi K
J Alzheimers Dis; 2012; 32(1):33-41. PubMed ID: 22751175
[TBL] [Abstract][Full Text] [Related]
6. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
7. The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment.
Ma L; Chen J; Wang R; Han Y; Zhang J; Dong W; Zhang X; Wu Y; Zhao Z
J Clin Neurosci; 2015 Apr; 22(4):649-52. PubMed ID: 25564275
[TBL] [Abstract][Full Text] [Related]
8. Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease.
Tsou HH; Hsu WC; Fuh JL; Chen SP; Liu TY; Wang HT
J Alzheimers Dis; 2018; 61(2):571-580. PubMed ID: 29226874
[TBL] [Abstract][Full Text] [Related]
9. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
[TBL] [Abstract][Full Text] [Related]
11. Clock Drawing Test: A Simple Scoring System for the Accurate Screening of Cognitive Impairment in Patients with Mild Cognitive Impairment and Dementia.
Rakusa M; Jensterle J; Mlakar J
Dement Geriatr Cogn Disord; 2018; 45(5-6):326-334. PubMed ID: 30036864
[TBL] [Abstract][Full Text] [Related]
12. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
[TBL] [Abstract][Full Text] [Related]
13. Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects.
Rostamzadeh A; Schwegler C; Gil-Navarro S; Rosende-Roca M; Romotzky V; Ortega G; Canabate P; Moreno M; Schmitz-Luhn B; Boada M; Jessen F; Woopen C
J Alzheimers Dis; 2021; 80(2):601-617. PubMed ID: 33554900
[TBL] [Abstract][Full Text] [Related]
14. Discrimination ability of the Short Test of Mental Status (STMS) compared to the Mini Mental State Examination (MMSE) in the spectrum of normal cognition, mild cognitive impairment, and probable Alzheimer's disease dementia: The Turkish standardization study.
Çebi M; Babacan G; Öktem Tanör Ö; Gürvit H
J Clin Exp Neuropsychol; 2020 Jul; 42(5):450-458. PubMed ID: 32406297
[TBL] [Abstract][Full Text] [Related]
15. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?
Pinto TCC; Machado L; Bulgacov TM; Rodrigues-Júnior AL; Costa MLG; Ximenes RCC; Sougey EB
Int Psychogeriatr; 2019 Apr; 31(4):491-504. PubMed ID: 30426911
[TBL] [Abstract][Full Text] [Related]
16. The Mini-Mental State Examination: Czech Norms and Cutoffs for Mild Dementia and Mild Cognitive Impairment due to Alzheimer's Disease.
Bartos A; Raisova M
Dement Geriatr Cogn Disord; 2016; 42(1-2):50-7. PubMed ID: 27536904
[TBL] [Abstract][Full Text] [Related]
17. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
18. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
19. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
20. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
